Neurologic manifestations of varicella zoster virus infections

Current Neurology and Neuroscience Reports

Volumn 9, Issue 6, 2009, Pages 430-434

  Amlie Lefond, Catherine ^a   Jubelt, Burk ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FAMCICLOVIR; PREDNISONE; VALACICLOVIR;

CEREBELLAR ATAXIA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CRANIAL NERVE PARALYSIS; DISEASE ASSOCIATION; HERPES ZOSTER; HERPES ZOSTER ENCEPHALITIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; MORBIDITY; MYELITIS; NEUROLOGIC DISEASE; PATHOGENESIS; PERIPHERAL PARALYSIS; POSTHERPETIC NEURALGIA; REVIEW; VARICELLA ZOSTER VIRUS; VASCULAR DISEASE; VIRUS REACTIVATION;

ANIMALS; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 70350168616     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-009-0064-z     Document Type: Review

References (50)

1. Whitley RJ: Varicella-zoster virus. In Principles and Practice of Infectious Diseases. Edited by Mandell GL, Bennett JE, Dolin R. New York: Churchill-Livingston; 1995:1345-1351.
2. Mahalingam R, Wellish M, Wolf W, et al.: Latent varicellazoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med 1990, 323: 627-631.
3. Baadsgaard O, Lindskov R, Geisler C: Reduction of the number of immunocompetent cells in the acute stage of herpes zoster. Arch Dermatol Res 1987, 279:374-378.
4. Hope-Simpson RE: The naAure of herpes zoster: a longterm study and a new hypothesis. Proc R Soc Med 1965, 58:9-20.
5. Watson CP, Deck JH,FMorshead C, et al.: Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991, 44:105-117.
6. Gilden DH, Wright RR, Schneck SA, et al.: Zoster sine herpete, a clinical variant. Ann Neurol 1994, 35:530-533.
7. Gilden DH, Gesser R, Smith J, et al.: Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes 2001, 23:145-147.
8. Linnemann CC Jr, Alvira MM: Pathogenesis of varicellazoster angiitis in the CNS. Arch Neurol 1980, 37:239-240.
9. Rosenblum WI, Hadfield MG, Young HF: Granulomatous angiitis with preceding varicella zoster. Ann Neurol 1978, 3:374-375.
10. Devinsky O, Cho ES, Petito CK, Price RW: Herpes zoster myelitis. Brain 1991, 114:1181-1196.
11. Gilden DH, Mahalingam R, Cohrs RJ, et al.: The protean manifestations of varicella-zoster virus vasculopathy. J Neurovirol 2002, 8(Suppl 2):75-79.
12. Weller TH: Varicella-herpes zoster virus. In Viral Infections of Humans: Epidemiology and Control. Edited by Evans AS. New York: Plenium; 1989:659-683.
13. Dangond F, Engle E, Yessayan L, Sawyer MH: Pre-eruptive varicella cerebellitis confirmed by PCR. Pediatr Neurol 1993, 9: 491-493.
14. Johnson R, Milbourn PE: Central nervous system manifestations of chickenpox. Can Med Assoc J 1970, 102:831-834.
15. Donahue JG, Choo PW, Manson JE, Platt R: The incidence of herpes zoster. Arch Intern Med 1995, 155:1605-1609.
16. Gilden DH, Hayward AR, Krupp J, et al.: Varicella-zoster virus infection of human mononuclear cells. Virus Res 1987, 7:117-129.
17. Ozaki T, Ichikawa T, Matsui Y, et al.: Viremic phase in nonimmunocompromised children with varicella. J Pediatr 1984, 104: 85-87.
18. Nagel MA, Cohrs RJ, Mahalingam R, et al.: The varicella zoster virus vasculopathies: Clinical, CSF, imaging, and virologic features. Neurology 2008, 70:853-860.
19. Portenoy RK, Duma C, Foley KM: Acute herpetic and postherpetic neuralgia: Clinical review and current management. Ann Neurol 1986, 20:651-664.
20. Gauthier A, Breuer J, Carrington D, et al.: Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009, 137:38-47.
21. Ragozzino MW, Melton LJ 3rd, Kurland LT, et al.: Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982, 61:310-316.
22. Gilden DH: Herpes zoster with postherpetic neuralgia-persisting pain and frustration. N Engl J Med 1994, 330:932-934.
23. Quan D, Hammack BN, Kittelson J, Gilden DH: Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir. Arch Neurol 2006, 63: 940-942.
24. Thomas JE, Howard FM Jr: Segmental zoster paresis - a disease profile. Neurology 1972, 22:459-466.
25. Kertes PJ, Baker JD, Noel LP: Neuro-ophthalmic complications of acute varicella. Can J Ophthalmol 1998, 33:324-328.
26. Lee CC, VeAketasubramanian N, Lam MS: Optic neuritis: a rare complication of primary varicella infection. Clin Infect Dis 1997, 24:515-516.
27. Gilden DH, Beinlich BR, Rubinstien EM, et al.: Varicellazoster virus myelitis: An expanding spectrum. Neurology 1994, 44: 1818-1823.
28. Horten B, Price RW, Jimenez D: Multifocal varicella-zoster virus leukoencephalitis temporally remote from herpes zoster. Ann Neurol 1981, 9:251-266.
29. Morgello S, Block GA, Price RW, Petito CK: Varicella-zoster virus leukoencephalitis and cerebral vasculopathy. Arch Pathol Lab Med 1988, 112:173-177.
30. Gray F, Belec L, Lescs MC, et al.: Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 1994, 117: 987-999.
31. Amlie-Lefond C, Kleinschmidt-Demasters BK, Mahalingam R, et al.: The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol 1995, 37:784-790.
32. Askalan R, Laughlin S, Mayank S, et al.: Chickenpox and stroke in childhood: A study of frequency and causation. Stroke 2001, 32:1257-1262.
33. Ganesan V, Kirkham FJ: Mechanisms of ischaemic stroke after chickenpox. Arch Dis Child 1997, 76:522-525.
34. Sebire G, Meyer L, Chabrier S: Varicella as a risk factor for cerebral infarction in childhood: A case-control study. Ann Neurol 1999, 45:679-680.
35. Schmidbauer M, Budka H, Pilz P, et al.: Presence, distribution and spread of productive varicella zoster virus infection in nervous tissues. Brain 1992, 115:383-398.
36. Hilt DC, Buchholz D, Krumholz A, et al.: Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: Diagnosis and management approaches. Ann Neurol 1983, 14:543-553.
37. Kuroiwa Y, Furukawa T: Hemispheric infarction after herpes zoster ophthalmicus: Computed tomography and angiography. Neurology 1981, 31:1030.
38. Melanson M, Chalk C, Georgevich L, et al.: Varicella-zoster virus DNA in CSF and arteries in delayed contralateral hemiplegia: Evidence for viral invasion of cerebral arteries. Neurology 1996, 47:569-570.
39. Lanthier S, Armstrong D, Domi T, deVeber G: Post-varicella arteriopathy of childhood: Natural history of vascular stenosis. Neurology 2005, 64:660-663.
40. Miravet E, Danchaivijitr N, Basu H, et al.: Clinical and radiological features of childhood cerebral infarction following varicella zoster virus infection. Dev Med Child Neurol 2007, 49:417-422.
41. Nagel MA, Forghani B, Mahalingam R, et al.: The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 2007, 68:1069-1073.
42. American Academy of Pediatrics Committee on Infectious Diseases: Prevention of varicella: Recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule. Pediatrics 2007, 120:221-231.
43. Oxman MN, Levin MJ, Johnson GR, et al.: A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352:2271-2284.
44. Tyring S, Barbarash RA, Nahlik JE, et al.: Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 1995, 123:89-96.
45. Beutner KR, Friedman DJ, Forszpaniak C, et al.: Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995, 39:1546-1553.
46. Madkan VK, Arora A, Babb-Tarbox M, et al.: Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older. J Cutan Med Surg 2007, 11:89-98.
47. Dubinsky RM, Kabbani H, El-Chami Z, et al.: Practice parameter: treatment of postherpetic neuralgia: An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004, 63:959-965.
48. Shepp DH, Dandliker PS, Meyers JD: Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine. N Engl J Med 1986, 314:208-212.
49. de Silva SMI Mark AS, Gilden DH, et al.: Zoster myelitis: improvement with antiviral therapy in two cases. Neurology 1996, 47:929-931.
50. Gilden DH, Kleinschmidt-Demasters BK, Laguardia JJ, et al.: Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000, 342:635-645.